Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Combination of pasireotide and everolimus feasible for neuroendocrine tumors

Feb. 2, 2010

Phase II data show everolimus monotherapy to be safe and active in metastatic gastric cancer

Feb. 2, 2010

Promising data disclosed on TNFerade for esophageal cancer

Feb. 2, 2010

Final phase II data support safety of picoplatin as alternative to oxaliplatin in metastatic CRC

Feb. 1, 2010

Spectrum receives payments from Nippon and Handok under agreements for EOquin

Feb. 1, 2010

DMI Life Sciences describes novel PKB/Akt and MMP-9 inhibitors

Feb. 1, 2010

Oncolytic choline kinase inhibitor TCD-717 to enter clinical development

Feb. 1, 2010

Studies demonstrate prediction of recurrence with Oncotype DX in colon cancer

Feb. 1, 2010

Novotyr Therapeutics presents IGF-1R inhibitors as antineoplastic agents

Feb. 1, 2010

Small molecules activating apoptotic procaspases identified

Feb. 1, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...